MaltSci 麦伴科研

Appearance

Popular Reports / Genomics

This report is written by MaltSci based on the latest literature and research findings

How does prime editing improve gene editing? ​

Abstract ​

Gene editing has emerged as a transformative technology in molecular biology, enabling precise modifications to the genomes of various organisms. The advent of tools such as CRISPR/Cas9 has significantly advanced our ability to manipulate genetic material, yet these methods often come with challenges, including unintended mutations and off-target effects. Prime editing, introduced in 2019, offers a more accurate and versatile approach to genome editing by allowing targeted insertions, deletions, and base substitutions without the need for double-strand breaks or donor DNA templates. This capability not only enhances precision but also minimizes the risk of unintended genetic alterations, making it a promising candidate for therapeutic applications. With an estimated 89% of known genetic variants associated with human diseases being correctable through prime editing, the implications for gene therapy are profound. Unlike traditional methods, prime editing's unique mechanism allows for the direct writing of genetic information into specified locations within the genome, paving the way for novel therapeutic strategies. This review elucidates the mechanisms underlying prime editing, highlights its advantages over existing gene editing technologies, and explores its potential applications in the medical field. Additionally, we address the challenges that must be overcome to facilitate the widespread implementation of this technology in clinical settings. The current landscape of prime editing research is rapidly evolving, with numerous studies focusing on its efficiency, precision, and delivery methods. Recent advancements have demonstrated the potential of prime editing in various contexts, including the correction of genetic mutations in patient-derived models and its applications in treating complex diseases such as cancer. Through this comprehensive overview, we aim to provide insights into how prime editing not only enhances the capabilities of gene editing but also holds the promise of transforming the landscape of genetic research and therapeutic interventions.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Prime Editing
    • 2.1 The Prime Editing System: Components and Functionality
    • 2.2 Comparison with Traditional CRISPR/Cas9 Techniques
  • 3 Advantages of Prime Editing
    • 3.1 Increased Precision and Reduced Off-Target Effects
    • 3.2 Versatility in Targeting Different Types of Genetic Modifications
  • 4 Applications in Medicine
    • 4.1 Potential for Treating Genetic Disorders
    • 4.2 Prime Editing in Cancer Research and Therapy
  • 5 Challenges and Limitations
    • 5.1 Technical Challenges in Delivery and Efficiency
    • 5.2 Ethical and Regulatory Considerations
  • 6 Future Perspectives
    • 6.1 Innovations on the Horizon
    • 6.2 The Role of Prime Editing in Personalized Medicine
  • 7 Conclusion

1 Introduction ​

Gene editing has emerged as a transformative technology in molecular biology, enabling precise modifications to the genomes of various organisms. The advent of tools such as CRISPR/Cas9 has significantly advanced our ability to manipulate genetic material, yet these methods often come with challenges, including unintended mutations and off-target effects. These limitations have spurred the development of more refined techniques, among which prime editing stands out as a groundbreaking innovation. Prime editing, introduced in 2019, offers a more accurate and versatile approach to genome editing by allowing targeted insertions, deletions, and base substitutions without the need for double-strand breaks or donor DNA templates [1]. This capability not only enhances precision but also minimizes the risk of unintended genetic alterations, making it a promising candidate for therapeutic applications [2][3].

The significance of prime editing lies in its potential to address a wide array of genetic disorders that arise from single-nucleotide mutations. With an estimated 89% of known genetic variants associated with human diseases being correctable through prime editing [1], the implications for gene therapy are profound. Unlike traditional methods, prime editing's unique mechanism allows for the direct writing of genetic information into specified locations within the genome, paving the way for novel therapeutic strategies [4]. This review aims to elucidate the mechanisms underlying prime editing, highlight its advantages over existing gene editing technologies, and explore its potential applications in the medical field. Additionally, we will address the challenges that must be overcome to facilitate the widespread implementation of this technology in clinical settings.

The current landscape of prime editing research is rapidly evolving, with numerous studies focusing on its efficiency, precision, and delivery methods. Recent advancements have demonstrated the potential of prime editing in various contexts, including the correction of genetic mutations in patient-derived models [5] and its applications in treating complex diseases such as cancer [3]. Furthermore, optimization strategies are being explored to enhance the performance of prime editing systems, including the use of engineered guide RNAs and modulation of DNA repair pathways [6][7].

In this review, we will first discuss the mechanisms of prime editing, including the components of the prime editing system and how it compares to traditional CRISPR/Cas9 techniques. We will then outline the advantages of prime editing, emphasizing its increased precision and versatility in targeting various types of genetic modifications. Following this, we will delve into the applications of prime editing in medicine, particularly its potential for treating genetic disorders and its role in cancer research and therapy. We will also examine the challenges and limitations that currently hinder the efficiency and accessibility of prime editing, including technical hurdles in delivery and ethical considerations surrounding its use. Finally, we will explore future perspectives on prime editing, highlighting innovations on the horizon and its potential role in personalized medicine.

Through this comprehensive overview, we aim to provide insights into how prime editing not only enhances the capabilities of gene editing but also holds the promise of transforming the landscape of genetic research and therapeutic interventions. As we stand on the cusp of a new era in gene editing, understanding the mechanisms, applications, and challenges of prime editing will be crucial for harnessing its full potential in addressing genetic diseases and advancing the field of molecular medicine.

2 Mechanisms of Prime Editing ​

2.1 The Prime Editing System: Components and Functionality ​

Prime editing represents a significant advancement in the field of genome editing, primarily due to its ability to make precise genetic modifications without the need for double-strand breaks (DSBs) or donor DNA templates. This technology relies on a unique system composed of several key components, which work together to facilitate targeted modifications at specific genomic sites.

The core components of a prime editing system include a prime editor fusion protein, which typically consists of a catalytically impaired Cas9 endonuclease (nickase) and an engineered reverse transcriptase (RT). This fusion protein is paired with a prime editing guide RNA (pegRNA), which not only specifies the target site within the genome but also encodes the desired edit. The pegRNA is structured to include a protospacer sequence that directs the editing process, a scaffold region that aids in binding the prime editor, and a reverse transcription template that provides the sequence for the intended genetic alteration [8].

One of the most notable advantages of prime editing is its versatility in introducing a wide array of genetic modifications. It can achieve all 12 types of base substitutions, targeted insertions, deletions, and even combinations of these edits without generating DSBs, which are often associated with unintended consequences and genomic instability. This precision significantly reduces the risk of off-target effects compared to traditional CRISPR/Cas9 systems [9].

The functionality of prime editing hinges on its mechanism, which involves the use of the reverse transcriptase to synthesize the desired DNA sequence at the target site after the pegRNA has guided the prime editor to the correct location. This process allows for the direct writing of new genetic information into the genome, enhancing the overall efficiency of gene editing. Recent studies have shown that optimized versions of prime editors, such as the engineered prime editors with enhanced reverse transcriptase capabilities, can achieve editing efficiencies significantly higher than earlier models, sometimes exceeding 80% in certain contexts [10].

Moreover, the development of dual pegRNA strategies has further expanded the scope of prime editing, allowing for the simultaneous targeting of multiple sites and increasing the editing efficiency [11]. Additionally, the optimization of delivery methods and the use of advanced systems to enhance chromatin accessibility have been pivotal in improving the performance of prime editing systems [8].

In summary, prime editing improves gene editing by offering a precise, efficient, and versatile method for genetic modifications, significantly minimizing off-target effects and expanding the range of achievable edits. Its innovative system of components and functionality marks a transformative step in genome engineering, with promising applications in therapeutic development and agricultural biotechnology [12][13].

2.2 Comparison with Traditional CRISPR/Cas9 Techniques ​

Prime editing represents a significant advancement in gene editing technologies, enhancing precision and versatility compared to traditional CRISPR/Cas9 methods. The fundamental mechanism of prime editing involves the use of a prime editor, which is a fusion protein composed of a Cas9 nickase and a reverse transcriptase (RT). This system allows for targeted modifications in the genome without inducing double-strand breaks (DSBs), which are characteristic of traditional CRISPR/Cas9 techniques.

In contrast to the conventional CRISPR/Cas9 approach, which relies on creating DSBs followed by the cell's repair mechanisms (homology-directed repair or non-homologous end joining), prime editing utilizes a prime editing guide RNA (pegRNA) that contains both a target sequence and the desired edit. The RT component of the prime editor synthesizes the desired DNA sequence directly at the target site, enabling precise insertions, deletions, and base substitutions without the risk of large deletions or unwanted insertions often associated with DSBs[14].

One of the key advantages of prime editing is its ability to facilitate all 12 types of nucleotide exchanges and arbitrary insertions or deletions, which are limited in traditional CRISPR/Cas9 methods. Traditional techniques primarily focus on knockouts or small modifications within a restricted range, whereas prime editing allows for a broader spectrum of edits, making it suitable for correcting a wide variety of genetic mutations[9].

Moreover, the efficiency of prime editing has been improved through various optimization strategies. These include modifications to the pegRNA, such as optimizing the length of the primer binding site and enhancing the RT template, which can lead to increased editing rates[15]. Recent studies have reported significant improvements in editing efficiency, such as achieving up to 66.7% precise gene editing in rice using an optimized prime editing system[16].

In terms of application, prime editing has been successfully implemented in both plant and mammalian systems, demonstrating its versatility across different organisms. For instance, enhanced prime editing systems have shown improved efficiency in goat cells and embryos, with editing efficiencies reported as high as 11.9%[17]. In plants, prime editing has enabled the introduction of nucleotide transversions and precise gene modifications that were challenging with traditional methods[18].

Furthermore, the potential of prime editing extends beyond agricultural applications to therapeutic uses in treating genetic disorders. Its precision minimizes off-target effects, which is a significant concern in gene therapy, thereby enhancing safety profiles for clinical applications[19]. Studies have indicated that prime editing can correct mutations associated with various hereditary diseases with minimal off-target activity, positioning it as a promising tool for future gene therapy[20].

In summary, prime editing improves gene editing through its innovative mechanism that circumvents the drawbacks of DSBs, allowing for a broader range of precise genetic modifications. Its optimization strategies have led to enhanced efficiency and applicability in both agricultural and therapeutic contexts, setting it apart from traditional CRISPR/Cas9 techniques.

3 Advantages of Prime Editing ​

3.1 Increased Precision and Reduced Off-Target Effects ​

Prime editing represents a significant advancement in genome editing technology, primarily due to its ability to achieve high precision in genetic modifications while minimizing off-target effects. This technique is distinguished by its unique mechanism that allows for the direct installation of various small edits into the genome without the need for double-strand breaks or donor DNA templates, which are commonly required in traditional CRISPR-Cas9 approaches.

One of the core advantages of prime editing is its precision. It utilizes a catalytically impaired Cas9 endonuclease fused to an engineered reverse transcriptase, along with a prime editing guide RNA (pegRNA) that specifies both the target site and the desired edit. This innovative design enables prime editing to execute a wide range of edits, including all 12 types of base substitutions, targeted insertions, deletions, and combinations thereof, without generating unwanted byproducts typical of other genome editing methods[1][21].

The reduced off-target effects associated with prime editing are particularly noteworthy. Studies have demonstrated that prime editing results in fewer unintended genetic alterations compared to traditional CRISPR systems. For instance, whole-genome sequencing of prime-edited clonal lines has shown an absence of genome-wide off-target effects, which underscores the therapeutic potential of this technology[5][22]. This is largely due to the specific targeting capabilities of pegRNAs and the lack of double-strand breaks, which are often the source of unintended genomic modifications in other editing methods[14].

Moreover, prime editing's ability to correct a wide array of genetic defects positions it as a versatile tool in therapeutic applications. It has been successfully employed in various cellular contexts, including patient-derived organoids and pluripotent stem cells, showcasing its efficacy in modeling and potentially treating genetic diseases[7][13]. The flexibility and precision of prime editing not only enhance its utility in basic research but also pave the way for its application in precision medicine, where targeted therapies can be developed to address specific genetic disorders.

In summary, prime editing enhances gene editing through increased precision and significantly reduced off-target effects, making it a powerful tool for both research and therapeutic applications in the field of genetics. The ongoing advancements in this technology are expected to further expand its capabilities and applications in various biological contexts[3][23].

3.2 Versatility in Targeting Different Types of Genetic Modifications ​

Prime editing represents a significant advancement in the field of genome editing, providing a highly versatile and precise method for making genetic modifications. Unlike traditional CRISPR techniques that often require double-strand breaks and donor DNA templates, prime editing allows for direct and targeted alterations to the genome, including all 12 types of base substitutions, small insertions, and deletions, without the need for these additional components. This capability is primarily attributed to its unique mechanism, which involves a catalytically impaired Cas9 endonuclease fused to a reverse transcriptase, along with a prime editing guide RNA (pegRNA) that specifies the target site and encodes the desired edit [1].

One of the key advantages of prime editing is its ability to perform a wide array of genetic modifications with high precision. This includes not only point mutations but also larger insertions and deletions, making it applicable for a variety of genetic contexts. For instance, prime editing has been successfully employed to correct pathogenic mutations in human pluripotent stem cells, demonstrating its potential for gene therapy applications [24]. Furthermore, prime editing has shown to be more efficient and produce fewer unintended byproducts compared to other genome editing techniques such as base editing and traditional CRISPR methods [6].

The versatility of prime editing extends to its application across different biological systems. It has been utilized in human cells, plants, and various model organisms, highlighting its broad applicability in both therapeutic and research settings [14]. In particular, prime editing's capability to generate diverse types of edits has been crucial for modeling genetic diseases and exploring gene function [23].

Moreover, recent advancements have enhanced the efficiency of prime editing systems through various optimization strategies, such as guide RNA engineering and protein engineering, which have improved the precision and scale of feasible edits [23]. This continuous evolution in prime editing technology promises to further expand its applicability, making it a powerful tool for both basic research and therapeutic interventions.

In summary, prime editing improves gene editing by providing a precise, versatile, and efficient method for a wide range of genetic modifications. Its unique mechanism and the ability to directly write genetic information into specific sites in the genome make it a groundbreaking approach in the field of genetic engineering, with profound implications for therapeutic development and precision genetic research [3].

4 Applications in Medicine ​

4.1 Potential for Treating Genetic Disorders ​

Prime editing (PE) represents a significant advancement in gene editing technologies, providing a more precise and versatile approach to genomic modifications compared to traditional methods. This innovative technique allows for targeted genetic alterations without inducing double-strand breaks or requiring donor DNA templates, thereby minimizing unintended byproducts and off-target effects.

One of the key advantages of prime editing is its ability to perform all 12 types of base substitutions, as well as insertions and deletions, at specific genomic locations. This capability enables the correction of a wide array of genetic mutations associated with various inherited disorders. For instance, prime editing has been shown to efficiently correct mutations responsible for conditions such as sickle cell disease and Tay-Sachs disease, demonstrating its potential for therapeutic applications in genetic disorders [25].

In the context of treating genetic disorders, prime editing's precision is particularly valuable. Traditional gene editing techniques, such as CRISPR-Cas9, often lead to unwanted edits due to the formation of double-strand breaks, which can result in indels or other genomic instability. In contrast, prime editing operates through a "search-and-replace" mechanism that directly writes new genetic information into target DNA sites, thus enhancing the accuracy of the edits and reducing the likelihood of harmful off-target effects [25].

Moreover, prime editing has shown promise in various therapeutic contexts, including the treatment of β-thalassemia, a blood disorder characterized by reduced levels of functional hemoglobin. Research indicates that PE can reactivate the γ-globin gene in patients, presenting a novel therapeutic strategy for this condition [26]. Similarly, its application in inherited retinal diseases highlights its versatility, as it can potentially correct mutations in larger genes that are otherwise challenging to address with conventional gene therapies [27].

Recent studies also emphasize the advancements in delivery methods for prime editing systems, which are crucial for their clinical application. Enhanced delivery vehicles, including viral vectors and nanoparticles, have been developed to improve the efficiency and safety of prime editing [28]. These innovations not only facilitate the in vivo application of PE but also expand its therapeutic potential across a range of genetic disorders.

However, despite its advantages, challenges remain in optimizing prime editing for clinical use. Issues such as delivery efficiency, off-target effects, and the need for further refinement of the technology must be addressed to fully realize its potential in the treatment of genetic disorders [29]. Ongoing research aims to enhance the precision and efficiency of prime editing systems, ensuring that they can be effectively utilized in clinical settings to address a broad spectrum of genetic diseases [23].

In conclusion, prime editing stands out as a transformative technology in the realm of gene editing, with significant implications for the treatment of genetic disorders. Its ability to make precise edits with minimal off-target effects, combined with ongoing advancements in delivery methods, positions it as a promising tool for future therapeutic applications in medicine.

4.2 Prime Editing in Cancer Research and Therapy ​

Prime editing represents a significant advancement in gene editing technologies, particularly in the context of cancer research and therapy. Unlike traditional CRISPR-Cas9 methods that rely on double-strand breaks (DSBs) to induce edits, prime editing allows for precise genetic modifications without creating DSBs, thereby minimizing the risk of unintended mutations and off-target effects. This unique mechanism enhances the precision and safety of genetic modifications, making it particularly suitable for therapeutic applications.

In cancer research, prime editing facilitates the accurate modeling of cancer-associated mutations within endogenous genetic contexts. This capability enables researchers to study the functional consequences of specific mutations, providing insights into tumorigenesis and potential therapeutic targets. For instance, recent studies have highlighted the utility of prime editing in addressing oncogenes and tumor suppressor genes, thereby aiding in the understanding of cancer biology and the development of targeted therapies[13].

Moreover, prime editing has shown promise in the treatment of various genetic disorders, including certain types of cancer. By enabling the correction of mutations that contribute to cancer progression, prime editing holds the potential to not only treat existing tumors but also to prevent the emergence of cancer by targeting pre-cancerous lesions. This preventive approach aligns with the growing interest in precision medicine, where treatments are tailored to the individual genetic makeup of patients[30].

Recent advancements in prime editing technologies have further improved their efficiency and applicability in therapeutic contexts. Innovations such as optimized delivery methods and engineered prime editor variants have expanded the range of possible edits, allowing for the correction of diverse mutations associated with cancer. Additionally, studies have demonstrated that prime editing can effectively model and potentially treat genetic diseases in patient-derived organoid cultures, offering a translational pathway for cancer therapies[29][31].

In summary, prime editing enhances gene editing by providing a precise, versatile, and safer approach to modifying genetic material. Its applications in cancer research and therapy are profound, as it enables accurate modeling of cancer mutations and the potential correction of these mutations, thereby contributing to the advancement of personalized medicine and innovative cancer treatment strategies[3][19].

5 Challenges and Limitations ​

5.1 Technical Challenges in Delivery and Efficiency ​

Prime editing is an innovative genome editing technology that enhances gene editing by allowing precise modifications without the need for double-strand breaks (DSBs) or donor DNA templates. This method utilizes a prime editor, which is a fusion of a Cas9 nickase and reverse transcriptase, alongside a prime editing guide RNA (pegRNA). The prime editing mechanism enables the introduction of all 12 types of base substitutions, as well as targeted insertions and deletions, making it a versatile tool in genetic research and therapeutic applications [9].

Despite its advantages, prime editing faces significant challenges, particularly concerning delivery and efficiency. The efficiency of prime editing remains a critical bottleneck, with reported editing efficiencies varying widely across different cell types and target sites. For instance, while some studies achieved up to 80% editing efficiency in certain contexts, others reported much lower rates, particularly in challenging cell types like human pluripotent stem cells, where efficiencies were around 50% [10].

Technical challenges in delivery are primarily attributed to the size of the prime editing components. The prime editor and pegRNA can be relatively large, complicating their delivery into target cells. Efficient delivery methods are crucial for maximizing the impact of prime editing, as demonstrated by studies that integrated stable genomic insertion of prime editors using transposon systems, enhanced promoters, and lentiviral delivery methods [10].

Moreover, the optimization of pegRNAs and prime editing enzymes is vital for improving overall editing outcomes. Researchers have developed various strategies to enhance the efficiency of prime editing, including engineered pegRNAs that stabilize the RNA structure and modifications to the reverse transcriptase to improve activity [11]. Additionally, environmental factors such as temperature and the design of the pegRNA significantly influence editing efficiency [32].

In summary, while prime editing represents a groundbreaking advancement in gene editing, its practical application is hampered by challenges related to delivery and efficiency. Ongoing research aims to address these limitations by refining delivery mechanisms and optimizing the components of the prime editing system, thereby expanding its potential for therapeutic applications and precision genetic research [19].

5.2 Ethical and Regulatory Considerations ​

Prime editing represents a significant advancement in the field of genome editing, offering improved precision and versatility compared to traditional methods such as CRISPR/Cas9. This technology allows for the introduction of a wide range of genetic modifications, including point mutations, insertions, and deletions, without the need for double-strand breaks or donor DNA templates. As a result, prime editing minimizes the risk of unintended consequences, such as indels and other undesired byproducts that are often associated with conventional editing techniques[7][10][12].

Despite its advantages, prime editing is not without challenges and limitations. One of the primary concerns is its variable efficiency across different genomic targets and cell types. While prime editing generally provides more precise editing outcomes, the efficiency can fluctuate significantly depending on the specific edits being made and the cellular context. For instance, systems that utilize a second nicking gRNA, such as PE3 and PE5, can enhance efficiency but may compromise precision, leading to unintended editing outcomes[7]. Furthermore, the editing efficiency of prime editing can be limited by the DNA repair processes in cells, which may not always favor the intended edits[33].

Moreover, there are ethical and regulatory considerations surrounding the application of prime editing technologies. The ability to make precise alterations to the genome raises questions about the potential for misuse, particularly in human germline editing. The prospect of editing human embryos or making heritable changes prompts a need for stringent regulatory frameworks to ensure that such technologies are used responsibly and ethically. As prime editing continues to evolve, it will be crucial to establish guidelines that address safety, efficacy, and ethical implications, particularly in clinical and agricultural applications[10][13].

In summary, while prime editing enhances gene editing by offering precise and versatile modifications with reduced off-target effects, challenges related to efficiency, potential unintended outcomes, and ethical considerations must be addressed to fully realize its potential in research and therapeutic contexts. The ongoing optimization of prime editing systems and the establishment of comprehensive regulatory frameworks will be essential for its responsible advancement in both biomedical and agricultural fields.

6 Future Perspectives ​

6.1 Innovations on the Horizon ​

Prime editing represents a significant advancement in gene editing technologies, providing a more precise and versatile approach to genomic modifications compared to traditional methods such as CRISPR/Cas9. This innovative technique operates without inducing double-strand breaks (DSBs) in DNA, which are common in conventional editing methods, thus reducing the likelihood of unintended genetic alterations and enhancing the overall specificity of edits. The key advantages and future perspectives of prime editing can be delineated as follows:

  1. Precision and Versatility: Prime editing allows for a wide range of genetic modifications, including all 12 types of base substitutions, targeted insertions, deletions, and the integration of large DNA fragments without the need for donor DNA templates. This capability significantly broadens the scope of potential applications in both therapeutic and agricultural contexts [9][14].

  2. Enhanced Editing Efficiency: Recent studies have focused on optimizing the efficiency of prime editing systems. For instance, engineered prime editors have been developed that significantly improve editing rates. An example is the introduction of modifications to reverse transcriptase that enhance the editing frequency in plant cells by 5.8-fold compared to earlier versions [11]. Additionally, dual-prime editing guide RNAs (pegRNAs) have been employed to further augment editing capabilities [7].

  3. Modulation of DNA Repair Pathways: Understanding and manipulating the DNA repair mechanisms involved in prime editing has emerged as a critical area of research. By pharmacologically inhibiting specific DNA repair pathways, researchers have been able to enhance the precision of various prime editing systems, thereby reducing off-target effects and improving the fidelity of edits [7]. This approach opens avenues for developing more refined editing tools that can target challenging genomic sites with higher accuracy.

  4. Applications in Therapeutics and Crop Improvement: Prime editing has shown promise in treating genetic disorders by precisely correcting mutations associated with diseases. In addition, its application in agricultural biotechnology could lead to the development of crops with desirable traits, such as enhanced resistance to diseases or improved nutritional profiles [13][19]. The versatility of prime editing makes it a valuable tool for both basic research and applied sciences.

  5. Future Innovations: As the field of prime editing evolves, there is a continuous effort to enhance the efficiency, specificity, and delivery methods of prime editing systems. Innovations on the horizon include the integration of advanced delivery mechanisms such as viral vectors and transposon systems to facilitate the introduction of prime editing components into target cells [34]. Moreover, the development of new prime editor variants that can efficiently target a broader range of genetic loci will further expand the utility of this technology.

In summary, prime editing stands at the forefront of gene editing innovations, with its ability to perform precise genomic alterations without DSBs setting it apart from traditional methods. Ongoing research aimed at optimizing its efficiency and understanding its underlying mechanisms will likely lead to transformative applications in medicine and agriculture, paving the way for novel therapeutic strategies and improved crop varieties in the near future.

6.2 The Role of Prime Editing in Personalized Medicine ​

Prime editing represents a significant advancement in the field of gene editing, offering enhanced precision and versatility compared to traditional methods. Unlike conventional techniques that often rely on double-strand breaks or donor DNA templates, prime editing utilizes a unique mechanism involving a catalytically impaired Cas9 endonuclease fused with a reverse transcriptase. This allows for direct writing of new genetic information into specified DNA sites, facilitating all 12 types of base substitutions, targeted insertions, and deletions without the complications associated with double-strand breaks[1].

One of the key advantages of prime editing is its ability to minimize unintended byproducts. Traditional editing methods, such as homology-directed repair (HDR), frequently lead to off-target effects, which can complicate the outcomes of genetic modifications. In contrast, prime editing has been shown to induce significantly lower off-target editing compared to other techniques, enhancing its safety profile for therapeutic applications[1]. Furthermore, prime editing can correct a vast majority of genetic defects, addressing conditions that arise from specific mutations, which is particularly beneficial in the context of personalized medicine[5].

The future of prime editing is closely linked to its potential role in personalized medicine. With the increasing recognition of the genetic basis of many diseases, prime editing offers a pathway to develop targeted therapies tailored to individual genetic profiles. This technology is currently being explored in various preclinical studies for conditions such as sickle cell disease, cystic fibrosis, and various hereditary disorders, demonstrating its capability to correct pathogenic mutations directly in patient-derived cells[20].

Moreover, recent innovations have focused on optimizing prime editing systems to improve their efficiency and applicability. Techniques such as dual-pegRNA strategies and co-inhibition of DNA repair pathways have been developed to enhance editing precision and reduce unwanted genetic alterations[7]. As these technologies advance, the therapeutic potential of prime editing is expected to expand, allowing for more complex genetic modifications and potentially leading to breakthroughs in the treatment of genetic diseases.

In summary, prime editing significantly improves gene editing by offering unparalleled precision, a reduced risk of off-target effects, and the capability to directly correct a wide array of genetic mutations. Its applications in personalized medicine hold promise for developing tailored therapeutic strategies that address the underlying genetic causes of diseases, thereby transforming the landscape of genetic therapy and precision medicine[2][3][13].

7 Conclusion ​

Prime editing represents a revolutionary advancement in the field of gene editing, characterized by its precision, versatility, and reduced off-target effects compared to traditional methods like CRISPR/Cas9. This innovative technology allows for a broad spectrum of genetic modifications, including all 12 types of base substitutions, targeted insertions, and deletions, without inducing double-strand breaks. The current research landscape highlights significant findings, such as prime editing's potential to correct a majority of genetic disorders and its applications in cancer research and therapy. However, challenges remain, particularly regarding delivery efficiency and ethical considerations surrounding its use in humans. Future research directions should focus on optimizing delivery methods, enhancing editing efficiencies, and addressing regulatory frameworks to ensure the safe and responsible application of prime editing in clinical settings. The promise of prime editing in personalized medicine, particularly its ability to tailor therapies to individual genetic profiles, signifies a transformative potential for treating genetic diseases and advancing therapeutic interventions in molecular medicine.

References ​

  • [1] Andrew V Anzalone;Peyton B Randolph;Jessie R Davis;Alexander A Sousa;Luke W Koblan;Jonathan M Levy;Peter J Chen;Christopher Wilson;Gregory A Newby;Aditya Raguram;David R Liu. Search-and-replace genome editing without double-strand breaks or donor DNA.. Nature(IF=48.5). 2019. PMID:31634902. DOI: 10.1038/s41586-019-1711-4.
  • [2] Mengyao Li;Yi Lin;Qiang Cheng;Tuo Wei. Prime Editing: A Revolutionary Technology for Precise Treatment of Genetic Disorders.. Cell proliferation(IF=5.6). 2025. PMID:40014809. DOI: 10.1111/cpr.13808.
  • [3] Jaesuk Lee;Jiyeon Kweon;Yongsub Kim. Emerging trends in prime editing for precision genome editing.. Experimental & molecular medicine(IF=12.9). 2025. PMID:40744998. DOI: 10.1038/s12276-025-01463-8.
  • [4] Yidian Fu;Xiaoyu He;Xin D Gao;Fang Li;Shengfang Ge;Zhi Yang;Xianqun Fan. Prime editing: current advances and therapeutic opportunities in human diseases.. Science bulletin(IF=21.1). 2023. PMID:37973465. DOI: 10.1016/j.scib.2023.11.015.
  • [5] Imre F Schene;Indi P Joore;Rurika Oka;Michal Mokry;Anke H M van Vugt;Ruben van Boxtel;Hubert P J van der Doef;Luc J W van der Laan;Monique M A Verstegen;Peter M van Hasselt;Edward E S Nieuwenhuis;Sabine A Fuchs. Prime editing for functional repair in patient-derived disease models.. Nature communications(IF=15.7). 2020. PMID:33097693. DOI: 10.1038/s41467-020-19136-7.
  • [6] Astrid Mentani;Marcello Maresca;Anna Shiriaeva. Prime Editing: Mechanistic Insights and DNA Repair Modulation.. Cells(IF=5.2). 2025. PMID:39996750. DOI: 10.3390/cells14040277.
  • [7] Louis C Dacquay;Panagiotis Antoniou;Astrid Mentani;Niklas Selfjord;Hanna Mårtensson;Pei-Pei Hsieh;Salman Mustfa;George Thom;Sandra Wimberger;Mike Firth;Nina Akrap;Marcello Maresca;Martin Peterka. Dual inhibition of DNA-PK and Polϴ boosts precision of diverse prime editing systems.. Nature communications(IF=15.7). 2025. PMID:40341582. DOI: 10.1038/s41467-025-59708-z.
  • [8] Ronghao Chen;Yu Cao;Yajing Liu;Dongdong Zhao;Ju Li;Zhihui Cheng;Changhao Bi;Xueli Zhang. Enhancement of a prime editing system via optimal recruitment of the pioneer transcription factor P65.. Nature communications(IF=15.7). 2023. PMID:36650182. DOI: 10.1038/s41467-023-35919-0.
  • [9] Xiaoxiao Yu;Guanzhong Huo;Jintai Yu;Huiyuan Li;Jun Li. Prime editing: Its systematic optimization and current applications in disease treatment and agricultural breeding.. International journal of biological macromolecules(IF=8.5). 2023. PMID:37769783. DOI: 10.1016/j.ijbiomac.2023.127025.
  • [10] Huiling Mu;Yeyi Liu;Yijia Chi;Fei Wang;Shuting Meng;Yi Zhang;Xunting Wang;Dongxin Zhao. Systematic optimization of prime editing for enhanced efficiency and versatility in genome engineering across diverse cell types.. Frontiers in cell and developmental biology(IF=4.3). 2025. PMID:40365017. DOI: 10.3389/fcell.2025.1589034.
  • [11] Yuan Zong;Yijing Liu;Chenxiao Xue;Boshu Li;Xiangyang Li;Yanpeng Wang;Ji Li;Guanwen Liu;Xingxu Huang;Xiaofeng Cao;Caixia Gao. An engineered prime editor with enhanced editing efficiency in plants.. Nature biotechnology(IF=41.7). 2022. PMID:35332341. DOI: 10.1038/s41587-022-01254-w.
  • [12] Irina O Petrova;Svetlana A Smirnikhina. The Development, Optimization and Future of Prime Editing.. International journal of molecular sciences(IF=4.9). 2023. PMID:38069367. DOI: 10.3390/ijms242317045.
  • [13] Joss B Murray;Patrick T Harrison;Janine Scholefield. Prime editing: therapeutic advances and mechanistic insights.. Gene therapy(IF=4.5). 2025. PMID:39609594. DOI: 10.1038/s41434-024-00499-1.
  • [14] Zhangrao Huang;Gang Liu. Current advancement in the application of prime editing.. Frontiers in bioengineering and biotechnology(IF=4.8). 2023. PMID:36873365. DOI: 10.3389/fbioe.2023.1039315.
  • [15] Pierre-François Perroud;Anouchka Guyon-Debast;Josep M Casacuberta;Wyatt Paul;Jean-Philippe Pichon;David Comeau;Fabien Nogué. Improved prime editing allows for routine predictable gene editing in Physcomitrium patens.. Journal of experimental botany(IF=5.7). 2023. PMID:37243510. DOI: 10.1093/jxb/erad189.
  • [16] Zhongsen Li;Rui Ma;Dan Liu;Mingyue Wang;Ting Zhu;Yanxue Deng. A straightforward plant prime editing system enabled highly efficient precise editing of rice Waxy gene.. Plant science : an international journal of experimental plant biology(IF=4.1). 2022. PMID:35905895. DOI: 10.1016/j.plantsci.2022.111400.
  • [17] Aicong Li;Zhenliang Zhu;Jing Yang;Yayi Liu;Yong Zhang;Jun Liu. Precise Insertion of AttB Sequences in Goat Genome Using Enhanced Prime Editor.. International journal of molecular sciences(IF=4.9). 2024. PMID:39273433. DOI: 10.3390/ijms25179486.
  • [18] Pierre-François Perroud;Anouchka Guyon-Debast;Florian Veillet;Marie-Paule Kermarrec;Laura Chauvin;Jean-Eric Chauvin;Jean-Luc Gallois;Fabien Nogué. Prime Editing in the model plant Physcomitrium patens and its potential in the tetraploid potato.. Plant science : an international journal of experimental plant biology(IF=4.1). 2022. PMID:35151447. DOI: 10.1016/j.plantsci.2021.111162.
  • [19] Olga V Volodina;Anastasia R Fabrichnikova;Arina A Anuchina;Olesya S Mishina;Alexander V Lavrov;Svetlana A Smirnikhina. Evolution of Prime Editing Systems: Move Forward to the Treatment of Hereditary Diseases.. Current gene therapy(IF=3.3). 2025. PMID:38623982. DOI: 10.2174/0115665232295117240405070809.
  • [20] Kelly Godbout;Jacques P Tremblay. Prime Editing for Human Gene Therapy: Where Are We Now?. Cells(IF=5.2). 2023. PMID:36831203. DOI: 10.3390/cells12040536.
  • [21] Nicolas Mathis;Ahmed Allam;Lucas Kissling;Kim Fabiano Marquart;Lukas Schmidheini;Cristina Solari;Zsolt Balázs;Michael Krauthammer;Gerald Schwank. Predicting prime editing efficiency and product purity by deep learning.. Nature biotechnology(IF=41.7). 2023. PMID:36646933. DOI: 10.1038/s41587-022-01613-7.
  • [22] Jackson Winter;Shraddha Shirguppe;Pablo Perez-Pinera. Protein Engineering Technologies for Development of Next-Generation Genome Editors.. Current opinion in biomedical engineering(IF=4.2). 2023. PMID:38095011. DOI: 10.1016/j.cobme.2023.100514.
  • [23] Hongzhi Zeng;Tyler C Daniel;Ananya Lingineni;Kelly Chee;Komal Talloo;Xue Gao. Recent advances in prime editing technologies and their promises for therapeutic applications.. Current opinion in biotechnology(IF=7.0). 2024. PMID:38330875. DOI: 10.1016/j.copbio.2024.103071.
  • [24] Omer Habib;Gizem Habib;Gue-Ho Hwang;Sangsu Bae. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.. Nucleic acids research(IF=13.1). 2022. PMID:35018468. DOI: 10.1093/nar/gkab1295.
  • [25] . ****. Zentralblatt fur Chirurgie(IF=0.5). 2019. PMID:31634968. DOI: 10.1055/a-1003-8271.
  • [26] Taqdees Arif;Aroosa Farooq;Fridoon Jawad Ahmad;Muhammad Akhtar;Mahmood S Choudhery. Prime editing: A potential treatment option for β-thalassemia.. Cell biology international(IF=3.1). 2023. PMID:36480796. DOI: 10.1002/cbin.11972.
  • [27] Silja Hansen;Michelle E McClements;Thomas J Corydon;Robert E MacLaren. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.. Cells(IF=5.2). 2023. PMID:36766782. DOI: 10.3390/cells12030440.
  • [28] Eric Deneault. Recent Therapeutic Gene Editing Applications to Genetic Disorders.. Current issues in molecular biology(IF=3.0). 2024. PMID:38785523. DOI: 10.3390/cimb46050255.
  • [29] Abhijith Koodamvetty;Saravanabhavan Thangavel. Advancing Precision Medicine: Recent Innovations in Gene Editing Technologies.. Advanced science (Weinheim, Baden-Wurttemberg, Germany)(IF=14.1). 2025. PMID:40025867. DOI: 10.1002/advs.202410237.
  • [30] Pankaj Garg;Gargi Singhal;Siddhika Pareek;Prakash Kulkarni;David Horne;Aritro Nath;Ravi Salgia;Sharad S Singhal. Unveiling the potential of gene editing techniques in revolutionizing Cancer treatment: A comprehensive overview.. Biochimica et biophysica acta. Reviews on cancer(IF=8.3). 2025. PMID:39638158. DOI: 10.1016/j.bbcan.2024.189233.
  • [31] Zhihan Zhao;Peng Shang;Prarthana Mohanraju;Niels Geijsen. Prime editing: advances and therapeutic applications.. Trends in biotechnology(IF=14.9). 2023. PMID:37002157. DOI: 10.1016/j.tibtech.2023.03.004.
  • [32] Sanskriti Vats;Jitesh Kumar;Humira Sonah;Feng Zhang;Rupesh Deshmukh. Prime editing in plants: prospects and challenges.. Journal of experimental botany(IF=5.7). 2024. PMID:38366636. DOI: 10.1093/jxb/erae053.
  • [33] Zhimeng Xu;Dacheng Ma;Houzhen Su;Xiaodong Jia;Yinqing Li;Yinying Lu;Zhen Xie. Explore the dominant factor in prime editing via a view of DNA processing.. Synthetic and systems biotechnology(IF=4.4). 2023. PMID:37325180. DOI: 10.1016/j.synbio.2023.05.007.
  • [34] Jonas Holst Wolff;Jakob Haldrup;Emil Aagaard Thomsen;Sofie Andersen;Jacob Giehm Mikkelsen. piggyPrime: High-Efficacy Prime Editing in Human Cells Using piggyBac-Based DNA Transposition.. Frontiers in genome editing(IF=4.4). 2021. PMID:34870275. DOI: 10.3389/fgeed.2021.786893.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

Precision Editing · Gene Therapy · Prime Editing Technology

© 2025 MaltSci